Skip to main content
. 2023 Jul 17;36(6):1663–1671. doi: 10.1007/s40620-023-01650-8

Table 3.

Severity of COVID-19 infection in the entire KTR cohort

Pre-vaccine infections (n = 66 pts) Infections after 2 doses (n = 6 pts) Infections after 3 doses (n = 51 pts)
Asymptomatic 0% 0% 60.8% (31 pts)
Mild symptoms 7.5% (5 pts) 33.3% (2 pts) 27.5% (14 pts)
Severe symptoms 65.2% (43 pts) 16.7% (1 pt) 3.9% (2 pts)
Hospitalization/death 27.3% (18/9 pts) 50% (3/0 pts) 7.8% (4/2 pts)